[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

July 2024 | 150 pages | ID: P798D618B976EN
Mordor Intelligence

US$ 4,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Pharmaceutical Logistics Market size in terms of Equal-5.53 is expected to grow from USD 531.42 billion in 2024 to USD 695.53 billion by 2029, at a CAGR of 5.53% during the forecast period (2024-2029).

Key Highlights

Pharmaceutical manufacturing companies are increasingly turning to third-party providers for packaging and labeling services. Many of these companies are expanding their operations into previously untapped regions like Sub-Saharan Africa and South America. However, they emphasize the importance of partnering with local logistics providers who possess strong expertise in pharmaceuticals. Despite the benefits, there are concerns about potential service quality deterioration and loss of control associated with outsourcing.

The demand for sea and air freight pharmaceutical logistics is expected to drive industry growth in the coming years. Sea freight, in particular, offers cost savings of up to 80% and reduces staffing needs while also minimizing packaging, storage, and carbon footprint. Air freight logistics are increasingly used for long-distance and intercontinental distribution of valuable vaccines and medicines, further contributing to industry expansion. The market is also witnessing increased demand for over-the-counter (OTC) medications such as vitamins, minerals, supplements (VMS), common cold and cough remedies, gastrointestinal drugs, and dermatology treatments.

Furthermore, there is a growing need for fast-track assistance in the healthcare sector, which is boosting the pharmaceutical logistics market. The establishment of a single-source distribution channel is seen as a way to reduce distribution costs and enhance efficiency in pharmaceutical logistics.

Pharmaceutical Logistics Market Trends

Increasing Demand for Cold Chain Logistics in the Sector

The cold chain logistics sector is poised for significant growth in the coming years. This expansion is primarily driven by increasing demand for ambient products, such as vaccines, necessitating precise temperature-controlled logistics to ensure product efficacy during distribution.

Government regulations mandating accurate temperature maintenance for highly temperature-sensitive pharmaceuticals are also expected to contribute to the segment's growth. The adoption of telematics in cold-chain pharmaceutical logistics is on the rise, enabling companies to improve efficiency, connectivity, and safety in cargo transportation. Given the requirement for temperature-controlled environments in the manufacturing and distribution of biological and medical products, pharmaceutical companies are increasingly relying on temperature-controlled transportation and cold storage systems.

Recent advancements in supply chain management and integration technologies have facilitated the seamless integration of effective cold-chain logistics for transporting temperature-sensitive goods. This has led to the growth of supply chain businesses while ensuring the quality and safety of pharmaceutical products. Overall, the provision of cold chain logistics by specialized firms is driving growth in the temperature-controlled logistics sector, promising a bright future for the industry.



Asia-Pacific is Poised to Witness the Highest Growth Rate

Asia-Pacific is poised to witness the highest growth rate in the future, primarily driven by a surge in demand for pharmaceutical products and substantial investments in healthcare infrastructure. For example, New Delhi, India, witnessed investments of INR 25,813 crore and the addition of 56,171 new jobs as of September 2023 under the production-linked incentive scheme for pharmaceuticals, as announced by the government of India.

Asia-Pacific is home to some of the world's largest and fastest-growing pharmaceutical markets, including China, India, Japan, and South Korea. The increasing demand for healthcare services and pharmaceutical products in these countries drives the need for efficient logistics solutions to ensure timely delivery.

Investments in transportation infrastructure, such as airports, seaports, and road networks, are improving logistics capabilities across the region. Modernization efforts aim to streamline the movement of pharmaceutical goods, reducing transit times and enhancing supply chain efficiency.



Pharmaceutical Logistics Industry Overview

The market is highly fragmented, with the presence of many companies across the globe. Some of the top names in this industry include DHL, DB Group, and FedEx. To maintain their position in the market, pharmaceutical logistics companies are continuously undertaking strategic initiatives such as mergers and acquisitions. Furthermore, players are investing in technologies such as telematics, remote sensing and monitoring, and GPS and GIS integration in transporting cargo, thereby providing customers with safe and convenient pharmaceutical logistics services.

Additional Benefits:

The market estimate (ME) sheet in Excel format

3 months of analyst support
1 INTRODUCTION

1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

2.1 Analysis Methodology
2.2 Research Phases

3 MARKET INSIGHTS AND DYNAMICS

3.1 Current Market Scenario
3.2 Government Initiatives and Regulatory Aspects
3.3 Technological Trends in the Industry
3.4 Market Dynamics
  3.4.1 Market Drivers
    3.4.1.1 Online Pharmacies to Facilitate Growth
    3.4.1.2 Increasing Demand for Over-the-counter (OTC) Medicines
  3.4.2 Market Restraints
    3.4.2.1 High Cost of Logistics
    3.4.2.2 Stringent Government Regulations
  3.4.3 Market Opportunities
    3.4.3.1 Increasing Investments in Drone Technology for Medication Delivery
3.5 Industry Attractiveness - Porter's Five Forces Analysis
  3.5.1 Bargaining Power of Suppliers
  3.5.2 Bargaining Power of Consumers/Buyers
  3.5.3 Threat of New Entrants
  3.5.4 Threat of Substitute Products
  3.5.5 Intensity of Competitive Rivalry
3.6 Value Chain/Supply Chain Analysis
3.7 Impact of COVID-19 on the Market

4 MARKET SEGMENTATION

4.1 By Product
  4.1.1 Generic Drugs
  4.1.2 Branded Drugs
4.2 By Mode of Operation
  4.2.1 Cold Chain Transport
  4.2.2 Non-Cold Chain Transport
4.3 By Application
  4.3.1 Biopharma
  4.3.2 Chemical Pharma
  4.3.3 Specialized Pharma
4.4 By Mode of Transport
  4.4.1 Air Shipping
  4.4.2 Rail Shipping
  4.4.3 Road Shipping
  4.4.4 Sea Shipping
4.5 Geography
  4.5.1 North America
    4.5.1.1 United States
    4.5.1.2 Canada
  4.5.2 Europe
    4.5.2.1 United Kingdom
    4.5.2.2 Germany
    4.5.2.3 France
    4.5.2.4 Italy
    4.5.2.5 Rest of Europe
  4.5.3 Asia-Pacific
    4.5.3.1 China
    4.5.3.2 India
    4.5.3.3 Japan
    4.5.3.4 South Korea
    4.5.3.5 Rest of Asia-Pacific
  4.5.4 Latin America
    4.5.4.1 Brazil
    4.5.4.2 Argentina
    4.5.4.3 Rest of Latin America
  4.5.5 Rest of the World

5 COMPETITIVE LANDSCAPE

5.1 Overview (Market Concentration and Major Players)
5.2 Company Profiles
  5.2.1 Deutsche Post DHL
  5.2.2 Kuehne + Nagel
  5.2.3 UPS (Marken)
  5.2.4 DB Group
  5.2.5 FedEx
  5.2.6 Nippon Express
  5.2.7 World Courier
  5.2.8 SF Express
  5.2.9 CEVA Logistics
  5.2.10 Agility
  5.2.11 DSV
  5.2.12 Kerry Logistics
  5.2.13 C.H. Robinson
  5.2.14 Air Canada Cargo
  5.2.15 Lineage Logistics
  5.2.16 United States Cold Storage
  5.2.17 Americold Logistics LLC
  5.2.18 Nichirei Logistics Group Inc.
  5.2.19 Kloosterboer
  5.2.20 NewCold Advanced Cold Logistics
  5.2.21 VersaCold Logistics Services
  5.2.22 Cloverleaf Cold Storage Co.*
5.3 Other Companies

6 FUTURE OF THE MARKET

7 APPENDIX

8 DISCLAIMER


More Publications